Product List
Brigatinib | 1197953-54-0
"
Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Abemaciclib | 1231929-97-7
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 1 | 1231930-42-9
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 2 | 1180132-17-5
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 3 | 1231930-37-2
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 4 | 1231930-33-8
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Alectinib Intermediate | 1256579-06-2
"
Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC). Al……
Cangrelor ( Not infringing ) | 163706-06-7
"
Cangrelor is a high-affinity, reversible inhibitor of P2Y12 as an antiplatelet drug. It is an active drug not requiring metabolic conversion. And ……
Alectinib Intermediate | 1256584-73-2
"
Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC). Al……